Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Nutrients
2023 Jan 11;152:. doi: 10.3390/nu15020378.
Show Gene links
Show Anatomy links
Sea Cucumber Derived Triterpenoid Glycoside Frondoside A: A Potential Anti-Bladder Cancer Drug.
Ru R
,
Chen G
,
Liang X
,
Cao X
,
Yuan L
,
Meng M
.
???displayArticle.abstract???
Bladder cancer is a highly recurrent disease and a common cause of cancer-related deaths worldwide. Despite recent developments in diagnosis and therapy, the clinical outcome of bladder cancer remains poor; therefore, novel anti-bladder cancer drugs are urgently needed. Natural bioactive substances extracted from marine organisms such as sea cucumbers, scallops, and sea urchins are believed to have anti-cancer activity with high effectiveness and less toxicity. Frondoside A is a triterpenoid glycoside isolated from sea cucumber, Cucumaria frondosa. It has been demonstrated that Frondoside A exhibits anti-proliferative, anti-invasive, anti-angiogenic, anti-cancer, and potent immunomodulatory effects. In addition, CpG oligodeoxynucleotide (CpG-ODN) has also been shown to have potent anti-cancer effects in various tumors models, such as liver cancer, breast cancer, and bladder cancer. However, very few studies have investigated the effectiveness of Frondoside A against bladder cancer alone or in combination with CpG-ODN. In this study, we first investigated the individual effects of both Frondoside A and CpG-ODN and subsequently studied their combined effects on human bladder cancer cell viability, migration, apoptosis, and cell cycle in vitro, and on tumor growth in nude mice using human bladder cancer cell line UM-UC-3. To interrogate possible synergistic effects, combinations of different concentrations of the two drugs were used. Our data showed that Frondoside A decreased the viability of bladder cancer cells UM-UC-3 in a concentration-dependent manner, and its inhibitory effect on cell viability (2.5 μM) was superior to EPI (10 μM). We also showed that Frondoside A inhibited UM-UC-3 cell migration, affected the distribution of cell cycle and induced cell apoptosis in concentration-dependent manners, which effectively increased the sub-G1 (apoptotic) cell fraction. In addition, we also demonstrated that immunomodulator CpG-ODN could synergistically potentiate the inhibitory effects of Frondoside A on the proliferation and migration of human bladder cancer cell line UM-UC-3. In in vivo experiments, Frondoside A (800 μg/kg/day i.p. for 14 days) alone and in combination with CpG-ODN (1 mg/kg/dose i.p.) significantly decreased the growth of UM-UC-3 tumor xenografts, without any significant toxic side-effects; however, the chemotherapeutic agent EPI caused weight loss in nude mice. Taken together, these findings indicated that Frondoside A in combination with CpG-ODN is a promising therapeutic strategy for bladder cancer.
Adrian,
The Anti-Cancer Effects of Frondoside A.
2018, Pubmed,
Echinobase
Adrian,
The Anti-Cancer Effects of Frondoside A.
2018,
Pubmed
,
Echinobase
Al Marzouqi,
Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts.
2011,
Pubmed
,
Echinobase
Al Shemaili,
Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer.
2014,
Pubmed
,
Echinobase
Al Shemaili,
Pharmacokinetics in Mouse and Comparative Effects of Frondosides in Pancreatic Cancer.
2016,
Pubmed
,
Echinobase
Aminin,
Immunomodulatory effects of holothurian triterpene glycosides on mammalian splenocytes determined by mass spectrometric proteome analysis.
2009,
Pubmed
Aminin,
Immunomodulatory action of monosulfated triterpene glycosides from the sea cucumber Cucumaria okhotensis: stimulation of activity of mouse peritoneal macrophages.
2010,
Pubmed
,
Echinobase
Aminin,
Immunomodulatory properties of frondoside A, a major triterpene glycoside from the North Atlantic commercially harvested sea cucumber Cucumaria frondosa.
2008,
Pubmed
,
Echinobase
Arnold,
Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity.
2020,
Pubmed
Attoub,
Frondoside a suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasis.
2013,
Pubmed
,
Echinobase
Attoub,
Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells.
2018,
Pubmed
,
Echinobase
Chuang,
Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade.
2020,
Pubmed
Dyshlovoy,
The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.
2016,
Pubmed
Dyshlovoy,
The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells.
2017,
Pubmed
,
Echinobase
Dyshlovoy,
Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells.
2017,
Pubmed
El-Elimat,
Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents.
2012,
Pubmed
Feng,
Cantharidin Inhibits Anti-Apoptotic Bcl-2 Family Proteins and Induces Apoptosis in Human Osteosarcoma Cell Lines MG-63 and MNNG/HOS via Mitochondria-Dependent Pathway.
2018,
Pubmed
Hassan,
Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy.
2016,
Pubmed
Hossain,
Northern Sea Cucumber (Cucumaria frondosa): A Potential Candidate for Functional Food, Nutraceutical, and Pharmaceutical Sector.
2020,
Pubmed
,
Echinobase
Hsu,
Exon 16-Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M-Positive Non-Small Cell Lung Cancer.
2020,
Pubmed
Jiang,
CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
2005,
Pubmed
Jin,
Differential effects of triterpene glycosides, frondoside A and cucumarioside A2-2 isolated from sea cucumbers on caspase activation and apoptosis of human leukemia cells.
2009,
Pubmed
,
Echinobase
Jin,
Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy.
2021,
Pubmed
Kundu,
Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties.
2014,
Pubmed
Li,
Review of the apoptosis pathways in pancreatic cancer and the anti-apoptotic effects of the novel sea cucumber compound, Frondoside A.
2008,
Pubmed
,
Echinobase
Liang,
CpG oligodeoxynucleotides enhance chemosensitivity of 5-fluorouracil in HepG2 human hepatoma cells via downregulation of the antiapoptotic factors survivin and livin.
2013,
Pubmed
Liu,
Neoantimycin F, a Streptomyces-Derived Natural Product Induces Mitochondria-Related Apoptotic Death in Human Non-Small Cell Lung Cancer Cells.
2019,
Pubmed
Luo,
CpG Oligodeoxynucleotide Promotes Apoptosis of Human Bladder Cancer T24 Cells Via Inhibition of the Antiapoptotic Factors.
2019,
Pubmed
Luo,
CpG Oligodeoxynucleotides Induces Apoptosis of Human Bladder Cancer Cells via Caspase-3-Bax/Bcl-2-p53 Axis.
2020,
Pubmed
Ma,
Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2.
2012,
Pubmed
,
Echinobase
Ming,
A trustworthy CpG nanoplatform for highly safe and efficient cancer photothermal combined immunotherapy.
2020,
Pubmed
Newman,
Natural Products as Sources of New Drugs from 1981 to 2014.
2016,
Pubmed
Pangestuti,
Medicinal and health benefit effects of functional sea cucumbers.
2018,
Pubmed
,
Echinobase
Sajwani,
Frondoside A potentiates the effects of conventional therapeutic agents in acute leukemia.
2017,
Pubmed
,
Echinobase
Sajwani,
Frondoside A is a potential anticancer agent from sea cucumbers.
2019,
Pubmed
,
Echinobase
Salindeho,
Anticancer and anticholesterol attributes of sea cucumbers: An opinion in terms of functional food applications.
2022,
Pubmed
,
Echinobase
Seidl,
Targets for Therapy of Bladder Cancer.
2020,
Pubmed
Sung,
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
2021,
Pubmed
Trenta,
Chemotherapy for Muscle-Invasive Bladder Cancer.
2016,
Pubmed
Wang,
Endoplasmic reticulum stress-mediated autophagy protects against β,β-dimethylacrylshikonin-induced apoptosis in lung adenocarcinoma cells.
2018,
Pubmed
Wu,
Exploring the Mechanism of Flaccidoxide-13-Acetate in Suppressing Cell Metastasis of Hepatocellular Carcinoma.
2020,
Pubmed
Yang,
Interferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response.
2018,
Pubmed
Zeng,
The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer.
2017,
Pubmed